Approval of esketamine for treatment-resistant depression
Author:
Publisher
Elsevier BV
Subject
Biological Psychiatry,Psychiatry and Mental health
Reference17 articles.
1. Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval;Turner;Lancet Psychiatry,2019
2. US Food and Drug Administration approval of esketamine and brexanolone;Cristea;Lancet Psychiatry,2019
3. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study;Popova;Am J Psychiatry,2019
4. Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis;Posternak;Br J Psychiatry,2007
5. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach;Fava;Psychother Psychosom,2003
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tailored Borneol-Modified Lipid Nanoparticles Nasal Spray for Enhanced Nose-to-Brain Delivery to Central Nervous System Diseases;ACS Nano;2024-08-19
2. Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022;Annals of Emergency Medicine;2024-08
3. Efficacy and safety of peri-partum Esketamine for prevention of post-partum depression in women undergoing caesarian section: A meta-analysis and systematic review of randomized controlled trials;Asian Journal of Psychiatry;2024-07
4. Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis;Frontiers in Psychiatry;2024-02-01
5. ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression in general psychiatry;Frontiers in Psychiatry;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3